BMO Capital analyst Sean Dodge upgraded HealthEquity to Outperform from Market Perform with a price target of $105, up from $85. The firm says recent developments increase its conviction in HealthEquity's longer-range growth outlook. AI fears around the company are overblown and provide investors with an attractive entry point, the analyst tells investors in a research note. BMO believes HealthEquity's recent Marketplace launch establish a new, large, and high-margin growth opportunity.
